Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 23, 2025 12:58 ET | Source: MJH Shared Services, LLC

MJH Life Sciences® and the American College of Cardiology collaborate to advance pharmacists’ role in cardiovascular care through education and clinical collaboration

CRANBURY, N.J., April 23, 2025 (GLOBE NEWSWIRE) -- MJH Life Sciences® announces a Strategic Alliance Partnership (SAP) between the American College of Cardiology (ACC) and two MJH premier brands,...
July 13, 2021 08:30 ET | Source: Daxor Corporation

American College of Cardiology (ACC) Features Expert Analysis on the Importance of Addressing Anemia With Blood Volume Analysis in Heart Failure Patients

Cites Evidence from Studies Utilizing Daxor’s BVA-100® Blood Volume Analyzer NEW YORK, July 13, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume...
March 30, 2020 07:30 ET | Source: Kiniksa Pharmaceuticals, Ltd.

Kiniksa Highlights Phase 2 Study Data Showing the Corticosteroid-Sparing Effect of Rilonacept in Patients with Recurrent Pericarditis at the American College of Cardiology's 69th Annual Scientific Session

- Phase 2 study data show the potential for rilonacept treatment to eliminate or reduce the risk of corticosteroid-associated morbidity in recurrent pericarditis - - Enrollment complete for the...
March 08, 2018 16:02 ET | Source: MyoKardia, Inc.

MyoKardia Announces Positive Results from Low-Dose Cohort of Phase 2 PIONEER-HCM Study of Mavacamten in Symptomatic, Obstructive Hypertrophic Cardiomyopathy Patients

Met Primary Endpoint and Key Secondary Endpoints with Statistical Significance Study Results Inform Phase 3 EXPLORER-HCM Dosing; First Patient Planned for Q2 2018 Conference Call Today...
March 08, 2013 08:00 ET | Source: On-X Life Technologies Inc.

Predicting Long-Term Costs of Heart Valve Replacement Study to be Presented at American College of Cardiology Meeting

AUSTIN, Texas, March 8, 2013 (GLOBE NEWSWIRE) -- On-X® Life Technologies, Inc. (On-X LTI) announced today that a cost analysis entitled, "Predicting Long-Term Costs of Heart Valve Replacement: A...
October 22, 2012 08:01 ET | Source: On-X Life Technologies Inc.

On-X Life Technologies Submits for FDA/CE Approval of Reduced Anticoagulation Indication for On-X Aortic Heart Valve

If approval is received, the On-X valve will become the first aortic valve that allows patients to be maintained at levels of anticoagulation below currently recommended professional society...